Methylphenidate prescribed for ADHD and bupropion used to treat depression, addiction, and seasonal affective disorder (SAD) also act as dopamine reuptake inhibitors (DRIs), a class of drugs that inhibit DAT activity [17]. This evidence concerns the gene SLC6A3 and depressive disorder.